SPG
45
2
HAL
40
11
FSLR
50
6
BAX
38
2
PEG
53
7
GOOGL
62
6
EMR
57
7
HCA
37
7
EXR
42
5
DVA
62
5
MCO
67
3
EOG
28
2
KHC
11
2
CTSH
55
3
SBUX
29
-2
AON
25
4
IVZ
42
13
INTC
35
4
DRI
74
5
SYK
50
4
SPG
45
2
HAL
40
11
FSLR
50
6
BAX
38
2
PEG
53
7
GOOGL
62
6
EMR
57
7
HCA
37
7
EXR
42
5
DVA
62
5
MCO
67
3
EOG
28
2
KHC
11
2
CTSH
55
3
SBUX
29
-2
AON
25
4
IVZ
42
13
INTC
35
4
DRI
74
5
SYK
50
4
Financhill
Back

CRISPR Therapeutics AG Vs. Novo Nordisk AS Industry Stock Comparison

Sell
28

CRSP
CRISPR Therapeutics AG

Last Price:
$40.74
Seasonality Move:
16.92%
Sell
23

NVO
Novo Nordisk AS

Last Price:
$85.00
Seasonality Move:
6.92%
Sell
28
CRISPR Therapeutics AG (CRSP) is a Sell

Is CRISPR Therapeutics AG a Buy, Sell or Hold?

  • The current CRISPR Therapeutics AG [CRSP] share price is $40.72. The Score for CRSP is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • CRSP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Novo Nordisk AS (NVO) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

  • The current Novo Nordisk AS [NVO] share price is $85.00. The Score for NVO is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CRSP Stock Price Chart

What is CRISPR Therapeutics AG's stock price today?

  • The CRISPR Therapeutics AG share price today is $40.72
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRSP is experiencing buying pressure, which is a positive indicator for future bullish movement.

NVO Stock Price Chart

What is Novo Nordisk AS's stock price today?

  • The Novo Nordisk AS share price today is $85.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing slight buying pressure.

CRSP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.05 Sell
Relative Strength Index (14 RSI): 33.92 Sell
Chaikin Money Flow: 1963017 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.97 - 51.27) Sell
Bollinger Bands (100): (45.2 - 50.74) Sell

NVO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.5 Sell
Relative Strength Index (14 RSI): 19.69 Sell
Chaikin Money Flow: 20899665 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (100.63 - 110.99) Sell
Bollinger Bands (100): (107.27 - 131.41) Sell

CRSP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 43.5 Sell
20-day SMA: 47.77 Sell
50-day SMA: 48.31 Sell
200-day SMA: 53.99 Sell
8-day EMA: 43.38 Sell
20-day EMA: 46.13 Sell
50-day EMA: 47.73 Sell
200-day EMA: 52.28 Sell

NVO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 104.71 Sell
20-day SMA: 106.65 Sell
50-day SMA: 109.28 Sell
200-day SMA: 126.25 Sell
8-day EMA: 102.07 Sell
20-day EMA: 105.53 Sell
50-day EMA: 110.02 Sell
200-day EMA: 118.09 Sell

CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.19 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.20 per share, and an increase next year of $0.14 per share.

Novo Nordisk AS Earnings Growth & NVO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.49 per share, and an increase next year of $0.72 per share.

CRISPR Therapeutics AG Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):